Navigation Links
4th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care
Date:7/19/2011

PARIS, July 19, 2011 /PRNewswire/ --


For the fourth year, the Fondation Médéric Alzheimer and Alzheimer's Disease International (ADI) are running Alzheimer's Awards for evidence-based psychosocial interventions for people with dementia and their carers. The purpose of the Award is to promote better care and share best practices. Applications can be submitted from today 19 July until 1 December 2011 at http://www.alz.co.uk/award.

Psychosocial research involves or relates to both the social and psychological aspects of a patient's life. Often this includes the relationship between the personal, internal environment and the wider social world, such as the influence of social and environmental factors on an individual's state of mind or behaviour. This type of research is aimed at supporting and enhancing the quality of life of people with Alzheimer's disease and their carers.

Two Alzheimer's Awards will be given, the first for the best evidence-based psychosocial intervention with a prize of  €18,000. The second award, of €7,000, will be given for the most promising evidence-based psychosocial intervention.

All project proposals and complete application forms should be submitted by email before 1 December 2011. The winners will receive their awards during the 27th International Conference of Alzheimer's Disease International in London, UK in March 2012.

Dementia is a syndrome that can be caused by a number of progressive disorders that affect memory, thinking, behavior and the ability to perform everyday activities. Alzheimer's disease is the most common type of dementia.

After age 65, the likelihood of developing dementia roughly doubles every five years. In the World Alzheimer Report 2010, ADI estimated that there are 35.6 million people living with dementia worldwide, increasing to 65.7 million by 2030 and 115.4 million by 2050. The worldwide costs of dementia exceeds 1% of global GDP, at US$604 billion.

The Fondation Médéric Alzheimer is a non-profit organisation that was created in 1999. It aims to increase the knowledge in social sciences related to Alzheimer's disease, to support and promote innovative field projects intended in helping people with Alzheimer's disease and their carers, and to instigate national surveys allowing the analysis of yearly evolutions and geographic disparities.

Alzheimer's Disease International was established in 1984. Just over 25 years later Alzheimer's Disease International is now the international federation of 76 Alzheimer associations around the world, and in official relations with the World Health Organisation.

Sarah Smith, +44(0)207-981-0880, s.smith@alz.co.uk



'/>"/>
SOURCE Alzheimer's Disease International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Porter Novelli Named Agency of Record for Prix Galien USA Awards
2. EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011
3. Next-Generation Pharmacist™ Awards Program Announces 2011 Finalists
4. U.S. Department of Defense Awards $2 Million to Brain Plasticity Inc. to Study Impact of Brain Training for Traumatic Brain Injuries
5. Masimo Pronto-7 Wins GOLD in the 2011 Medical Design Excellence Award Competition—the Premier Awards Program for the Medical Technology Community
6. NCIIA Funds University Biomedical Engineering Teams at BMEidea Awards
7. Healthmark Industries Honored With Two Awards
8. UBM Canon and Medical Design Excellence Awards (MDEA) Announce Winner of Lifetime Achievement Award
9. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
10. 2011 CPhI Innovation Awards Open for Entries
11. Department of Defense Awards LifePort Five-Year Contract for Up to $45.5 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve as ... tenure, Paul has served us in multiple leadership roles since ... in Jun. 2015 and has provided decisive, strategic leadership which ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
Breaking Medicine Technology:
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with ... If so, you may be interested in participating in a research study that focuses ... is to understand more about the relational aspects of adults who have gluten sensitivities ...
(Date:8/19/2017)... Rockville, MD (PRWEB) , ... August 18, 2017 ... ... Food and Drug Administration Reauthorization Act of 2017, legislation that provides for greater ... perceived mild to moderate hearing loss to access OTC hearing aids without being ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. Noppadon Pakprot, Deputy Governor ... Thailand Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest “Functional ... Tourism Products and Business at TAT said, “Thailand has long been recognized as ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , In ...
Breaking Medicine News(10 mins):